Hydroxyurea Capsules USP 500mg Technical Specification:

Product Name:Hydroxyurea Capsules USP 500mg
Brand Name:Tharolax
Strength:200mg, 300mg, 400mg, 500mg
Dosage Form:Hard – Gelatin capsule
Packing:10s, 50s, 60s, 100s
Route of Administration:For Oral use only.
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use:Anti-Cancer
Indication: Hydroxyurea is used to treat cancer of the white blood cells called chronic myeloid leukemia (CML). It may also be given together with radiation treatment for head and neck cancer (advanced squamous cell cancer). Hydroxyurea interferes with the growth of cancer cells, which are eventually destroyed by the body.
Storage:Store at 25°C (77° F); excursions permitted to 15°C to 30°C (59° to 86° F). Do not refrigerate.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Hydroxyurea Capsules USP 500mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Hydroxyurea Capsules USP 500mg
    Each hard gelatin capsule contains:
    Hydroxyurea USP………………500mg
    Excipients………………………….q.s.
    Colours: Approved colours used in capsule shell

THERAPEUTIC INDICATION:

Hydroxyurea is used to treat cancer of the white blood cells called chronic myeloid leukemia (CML). It may also be given together with radiation treatment for head and neck cancer (advanced squamous cell cancer). Hydroxyurea interferes with the growth of cancer cells, which are eventually destroyed by the body.

CAUTION & WARNING:

WARNING: Cytotoxic Agent: To be supplied on demand from Cancer Hospitals, Institutions & on prescription of an Oncologist only.

WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an Oncologist/ Cancer Hospital/ Institution only.

CAUTION: It is dangerous to take this preparation except under medical supervision.

Swallow capsules whole. Do not chew, dissolve or open the capsules.

Keep out of the reach of the children.

STORAGE & DOSAGE:

Storage: Store at 25°C (77° F); excursions permitted to 15°C to 30°C (59° to 86° F).

Do not refrigerate.

Dosage: As directed by an Oncologist.

GENERIC NAME OF THE MEDICINAL PRODUCT:

a) Hydroxyurea Capsules USP 200mg
b) Hydroxyurea Capsules USP 300mg
c) Hydroxyurea Capsules USP 400mg
d) Hydroxyurea Capsules USP 500mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

a) Hydroxyurea Capsules USP 200mg
Each hard gelatin capsule contains:
Hydroxyurea USP………………200mg
Excipients………………………….q.s.
Colours: Approved colours used in capsule shell

b) Hydroxyurea Capsules USP 300mg
Each hard gelatin capsule contains:
Hydroxyurea USP……………….300mg
Excipients…………………………..q.s.
Colours: Approved colours used in capsule shell

c) Hydroxyurea Capsules USP 400mg
Each hard gelatin capsule contains:
Hydroxyurea USP………………..400mg
Excipients……………………………q.s.
Colours: Approved colours used in capsule shell

d) Hydroxyurea Capsules USP 500mg
Each hard gelatin capsule contains:
Hydroxyurea USP……………….500mg
Excipients…………………………..q.s.
Colours: Approved colours used in capsule shell


THERAPEUTIC INDICATION:

Hydroxyurea is used to treat cancer of the white blood cells called chronic myeloid leukemia (CML). It may also be given together with radiation treatment for head and neck cancer (advanced squamous cell cancer). Hydroxyurea interferes with the growth of cancer cells, which are eventually destroyed by the body.

CAUTION & WARNING:

WARNING: Cytotoxic Agent: To be supplied on demand from Cancer Hospitals, Institutions & on prescription of an Oncologist only.
WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an Oncologist/ Cancer Hospital/ Institution only.
CAUTION: It is dangerous to take this preparation except under medical supervision.
Swallow capsules whole. Do not chew, dissolve or open the capsules.
Keep out of the reach of the children.

STORAGE & DOSAGE:

Storage: Store at 25°C (77° F); excursions permitted to 15°C to 30°C (59° to 86° F).
Do not refrigerate.
Dosage: As directed by an Oncologist.